List of Contents
What is the Homecare Diagnostics and Therapeutics Market Size?
The global homecare diagnostics and therapeutics market size is calculated at USD 269.92 billion in 2025 and is predicted to increase from USD 291.51 billion in 2026 to approximately USD 577.56 billion by 2035, expanding at a CAGR of 7.90% from 2026 to 2035.
Homecare Diagnostics and Therapeutics Market Key Takeaways
- North America dominated the market in 2025.
- Asia Pacific is expected to witness rapid growth throughout the forecast period.
- By product, the diagnostics segment dominated the market in 2025.
- By service, the skilled nursing services segment led the market in 2025.
- By indication, the cardiovascular disorders segment held a large share of the market in 2025.
What are Homecare Diagnostics and Therapeutics?
The homecare diagnostics and therapeutics market deals with a wide range of healthcare products, such as nebulizers and blood glucose level indicators, which offer individuals adequate physical support, diagnosis, and healthcare monitoring. These user-friendly and portable devices allow patients to receive treatment from the comfort of their own homes and prevent costly hospital spending. The market has witnessed significant growth in the past few years. The demand for medical devices has increased exponentially during the COVID-19 pandemic due to the rising awareness about health & wellness. Moreover, the market is expected to grow in the coming years owing to the increasing usage of mHealth techniques, such as smartphone apps and wearables, the rising adoption of user-friendly and portable diagnostics & therapeutics devices, and the growing usage of telemedicine services.
How is AI contributing to the home Homecare Diagnostics and Therapeutics Industry?
Artificial Intelligence enables health care professionals to work faster and more efficiently by applying algorithms that can learn, interpret, and support through diagnostics and therapeutics, among others, the medical information. It helps the radiology and rehabilitation departments, enhances decision-making by extracting the most relevant evidence from clinical literature, and keeps doctors updated with medical knowledge.
Such tools can help streamline the data review process, improve workflow, accelerate the diagnosis process, and provide smart assistance for planning treatments. The integration plays an important role by supporting personalized care at home through allowing informed decision-making, better patient monitoring, and providing efficient guidance for therapy management.
Homecare Diagnostics and Therapeutics Market Growth Factors
The global homecare diagnostics and therapeutics market is primarily driven by several factors, such as the growing geriatric population, the rising prevalence of various chronic diseases, the increasing demand for convenient and quality healthcare services, and the rising technological advancements in home care tools. Some chronic diseases often require continuous monitoring of health status to prevent life-threatening events. However, telehealth plays a crucial role in homecare diagnostics & therapeutics, as it allows patients to access healthcare services remotely and manage their conditions remotely, thus reducing frequent and unnecessary hospital visits. The proliferation of digital technologies, the rising adoption of smartphones, and improving access to the internet are the major factors that boosted the adoption of telehealth applications across the globe. Moreover, favorable government frameworks for encouraging the adoption of telehealth to reduce the pressure on hospitals have significantly driven the adoption of telehealth.
Furthermore, the rising awareness regarding hospital-acquired infections among the population is compelling consumers to opt for homecare health services. According to the World Health Organization, around 7% of hospitalized patients in developed countries and 10% in developing countries are expected to acquire at least one healthcare-associated infection. Urinary tract infections are the most frequent hospital-acquired infection in developed countries. Moreover, the growing geriatric population is a major factor propelling the homecare diagnostics and therapeutics market.
- According to the World Health Organization, the number of people aged 60 or above is expected to reach about 2.1 billion by 2050.
Homecare Diagnostics and Therapeutics Market Outlook
The industry is increasing due to the aging population, the rise of chronic diseases, and thereby the demand for home diagnostics and therapeutics across the world.
The focus of sustainability is the use of fewer resources, less waste, and the adoption of green technologies, accompanied by digitalization, which will make the services more accessible and the environmental outcomes better.
The expansion is mainly through North America, with the rapid growth of the Asia Pacific markets being a strong factor due to the growing awareness and thus adoption of home care solutions being widespread.
Some of the major investors are Blume Ventures, Atlas Venture, Quest Diagnostics, Revvity, and Omron Healthcare, which are supporting the innovation, giving financial backing for growth, and making the initiatives possible.
The flourishing startup ecosystem is playing an important role in the development of new digital platforms, AI, and data, which are being used to tackle healthcare issues and create new business opportunities rapidly.
Market Scope
| Report Coverage | Details |
| Market Size in 2025 | USD 269.92 Billion |
| Market Size in 2026 | USD 291.51 Billion |
| Market Size by 2035 | USD 577.56 Billion |
| Growth Rate from 2026 to 2035 | CAGR of 7.90% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | Product, Service, Indication, and Region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
Market Dynamics
Driver
Reduction of hospital readmissions and enhanced safety
For patients with chronic diseases, hospital readmissions are a common concern. In certain health conditions, people face difficulties in moving out; hence, homecare diagnostics and therapeutics play a crucial role in treating such patients. Home care services offer immediate intervention and allow patients to monitor their health from the comfort of their own homes, which can avoid complications that may cause readmission. This approach further reduces frequent hospital and emergency room visits and minimizes additional healthcare costs. In addition, homecare provides a safer alternative to institutional care. Moreover, the increasing demand for cost-effective healthcare services, the trend of self-care, and the rising adoption of medical devices drive the market during the forecast period.
Restraint
High cost and lack of reimbursement policies
The high cost associated with homecare services restrains the market. The low affordability of people in developing and underdeveloped countries may deter them from adopting homecare diagnostics & therapeutics services, creating significant market challenges. Furthermore, the lack of reimbursement policies for homecare services makes them expensive, thus creating barriers for low-income people to adopt them.
Opportunity
Advancements in home care tools
The rising technological advancements in home care tools create lucrative opportunities in the market. Advanced technologies, such as data analytics, wireless connectivity, and artificial intelligence, are significantly boosting the adoption of several homecare diagnostic and therapeutic devices around the world. Healthcare providers are also adopting these technologies to reduce healthcare costs. For instance,
- In June 2024, an Oklahoma City-based startup, Apricot, leveraged generative AI to minimize healthcare documentation, allowing home-health nurses to concentrate more on patient care.
Homecare Diagnostics and Therapeutics Market Segment Insights
Product Insights
The diagnostics segment dominated the global market in 2025. This is attributed to the increased prevalence of various chronic diseases such as cancer, diabetes, respiratory disorders, and arthritis. The need for continuous monitoring of health conditions has fueled the growth of the diagnostics segment. The continuous research and development activities adopted by top market players have resulted in the development of technologically advanced homecare diagnostic products, contributing to segmental growth.
The mobility care products segment is anticipated to expand at the fastest growth rate during the forecast period. The rising number of bone fractures and road traffic accidents is fueling the growth of mobility care products like wheelchairs. Certain health conditions require patients to have assistance moving from one place to another.
Service Insights
The skilled nursing services segment dominated the global market in 2025. This is attributed to the rising adoption of skilled nursing services at home owing to the increasing geriatric population. Skilled nursing services provide more comforting solutions to patients than in a hospital or a nursing home. These services further improve patient outcomes, satisfaction, and access while reducing the total cost of care. For instance,
- In October 2022, Flare Capital Partners and Allina Health announced the launch of Inbound Health, a new company that enables health plans and health systems to offer skilled nursing-at-home and hospital-at-home programs.
The rehabilitation services segment is expected to be the fastest-growing segment during the forecast period. This is attributed to the rising popularity of telerehabilitation across the globe. Moreover, the growing adoption of wearable rehabilitation products like wearable robotic exoskeletons, coupled with the rising adoption of technologies like virtual reality in physiotherapies, is expected to drive the segment growth in the forthcoming years.
Indication Insights
The cardiovascular disorders segment led the market with the largest share in 2025. A significant increase in unhealthy food habits, changing lifestyles, obesity, and physical inactivity leads to the increased prevalence of cardiovascular disorders. According to the World Health Organization (WHO), cardiovascular disorders are the leading cause of death around the globe, accounting for around 32% of global death. Thus, cardiovascular patients require regular monitoring and therapeutics, which fueled the growth of this segment.
The diabetes segment is estimated to be the most opportunistic segment during the forecast period, owing to the increasing instances of diabetes. According to the data revealed by the International Diabetes Federation, around 552 million people across the globe are estimated to have diabetes by the year 2030. According to the World Health Organization, diabetes is a major cause of blindness, stroke, and kidney failure. Therefore, diabetes patients often require diagnostics and therapeutic devices to manage their conditions.
Homecare Diagnostics and Therapeutics Market Regional Insights
North America dominated the global homecare diagnostics & therapeutics market in 2025. The increased disposable income, high healthcare expenditure, increasing awareness regarding the hospital acquired infections, and presence of huge geriatric population are the major forces that shaped the North America homecare diagnostics & therapeutics market. Moreover, around half of the US population is suffering from at least one chronic diseases, which has significantly impacted the growth of the market in the region. Moreover, the higher adoption rate of the digital technologies like telehealth is significantly contributing towards the growth of the homecare diagnostics and therapeutics market.
North America has a predominant position in the market due to the presence of a well-established healthcare infrastructure, high awareness of medical conditions and treatments, and a favorable regulatory environment with pricing and reimbursement. The emphasis of the area is still to reduce the number of people getting back to hospitals after receiving treatment and to gradually transfer the treatment process from the hospital to the home, which includes using telemedicine to monitor patients conveniently and thus, having good and inexpensive medical management.
U.S. Homecare Diagnostics and Therapeutics Market Trends
The U.S. is moving towards a more equitable healthcare system with technology-based home care devices and supportive government policy initiatives. The integration of real-time monitoring opens up vast opportunities in diagnostics and therapeutic homecare solutions, which in turn lead to patient engagement and expansion of smart healthcare. This is happening within the context of evolving digital medical ecosystems
Asia Pacific is estimated to be the fastest-growing market during the forecast period. Asia Pacific is characterized by rising urban population, rising penetration of healthcare facilities, growing adoption of the digital technologies in the healthcare sector, growing geriatric population, rising personal disposable income, and rising healthcare expenditure, which favors the growth of the homecare diagnostics & therapeutics market in the region. According to the United Nations, around 80% of the global geriatric population will be living in the low and middle income countries. Moreover, the rising road traffic accidents is fueling the demand for the homecare services. According to the World Health Organization, around 93% of the road traffic accidents occur in the low and middle income countries.
The Asia Pacific region is experiencing the highest growth rate due to the large number of patients, the elderly population, and the increasing investment in home healthcare infrastructure. The early stages of adoption have a great potential for diagnostic and therapeutic providers as the home healthcare awareness continues to firm up and the technology-based platforms spread across the markets.
India Homecare Diagnostics and Therapeutics Market Trends
India is seen as a high-growth market due to the increase in lifestyle-related diseases, rise in disposable income, and the emergence of digital home care platforms. The demand for devices that are connected for monitoring chronic conditions is increasing, which, in turn, is also expanding the market for advanced therapeutic products in the country.
The chronic disease burden in Europe is rising and thus increasing the market for home diagnostics and therapeutics. The adoption of digital health is further accelerated by monitoring tools approved for use in clinical communication that empower patients to take care of their long-term conditions, and thus reduce the healthcare system's burden via remote assistance.
The UK Homecare Diagnostics and Therapeutics Market Trends
The NHS is helping the UK with digital monitoring tools that facilitate the management of chronic diseases. The main aspects of the future vision are patient empowerment, self-care solutions, efficient communication with clinicians, and extended use of technology-assisted home diagnostics that make healthcare more accessible and improve long-term outcomes.
Homecare Diagnostics and Therapeutics Market Value Chain
The very first stage in the process of discovering and developing new drug candidates or therapeutic agents that will eventually be marketed.
Key Players: Pfizer, Merck & Co., and Roche
Controlled administration of drugs to humans for the purpose of testing their safety and efficacy, followed by regulatory authorization compliance.
Key Players: IQVIA, Parexel, and ICON
The process of turning active ingredients into forms that are stable and ready for use, like tablets, capsules, or injectables.
Key Players: Catalent, Lonza, and Patheon
Finished products are placed into protective packaging, and unique identifiers are applied for tracking, tracing, ensuring the authenticity of the product, and safety.
Key Players: Amcor, Gerresheimer AG, and West Pharmaceutical Services
The logistics and supply chain for distributing finished products to hospitals, pharmacies, home care, diagnostics, and therapeutics providers.
Key Players: McKesson Corporation, Cardinal Health, and AmerisourceBergen
Homecare Diagnostics & Therapeutics Market Companies
The Fresenius Group is involved in the manufacturing of home dialysis systems such as the NxStage Versi HD, along with the GuideMe Software, which is meant for chronic kidney care assistance.
GE Healthcare is in the business of providing diagnostic telemonitoring in the form of cardiovascular ultrasound devices that are not only very efficient for home care but also have an easy-to-use interface.
The medical gases supplier Linde plc provides services, including oxygen and other medical gases, that are crucial in the case of home respiratory therapies, patient support, and comfort at home.
Other Major Companies
- F. Hoffmann-La Roche Ltd.
- A&D Company
- BAYADA Home Health Care
- Invacare Corporation
- Abbott
- Amedisys
- ResMed
Recent Developments in the Homecare Diagnostics and Therapeutics Industry
- In August 2025, Nonin Medical launched the Nonin Health platform, a cloud-based system aiding DME/HME providers, sleep dentists, and labs in managing oxygen and sleep-related care for millions of patients efficiently. The platform enables remote access to testing results, making healthcare providers deliver therapy timely and cost-effectively.
(Source: respiratory-therapy.com) - In April 2025, Cipla Foundation, in collaboration with CanSupport, initiated free palliative home care services in Pune, targeting over 900 cancer patients through nine teams across Pune City and four talukas: Haweli, Khed, Bhor, and Purandar.
(Source: expresshealthcare.in) - In September 2023, Apollo Hospitals launched India's first Comprehensive Connected Care program powered by Apollo's Connected Care technology. This service offers nursing staff and clinical teams across various care touchpoints and patient journeys, such as home care, post-surgery, Inpatient, emergency, and ambulance.
- In July 2023, Allied Insurance Company and Star Health launched home healthcare services in 50 towns and cities in India. The aim behind this launch was to provide healthcare service at the doorstep of the customers.
Segments Covered in the Report
By Product
- Diagnostics
- Therapeutics
- Mobility Care Products
By Service
- Rehabilitation Therapy Services
- Skilled Nursing Services
- Respiratory Therapy Services
- Pregnancy Care Services
- Infusion Therapy Services
- Others
By Indication
- Cardiovascular Disorders
- Cancer
- Diabetes
- Respiratory Diseases
- Wound Care
- Others
By Region
- North America
- Europe
- Asia-pacific
- Latin America
- Middle and East Africa
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
Frequently Asked Questions
Ask For Sample
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client